Resource Hub
Here you’ll find insightful articles, webinars, and learning guides.
Unlocking the Value of a Patent
In the right legal and business context, a well-planned patent can yield an exponential ROI when compared to the costs of procuring it.
IP and Investors: What Startups Need to Know
Prepare for investment with the most commonly asked questions investors will have about your IP.
Top 5 IP Considerations for Medical Device Startups
A primer on FTO, Patents, Trade Secrets, Trademarks & Copyright.
Be Investable, Acquirable and Successful: IP for MedTech Startups
Project Medtech Episode 152 | featuring Edward Steakley, Managing Partner at Cognition IP and Devon Campbell, Founder at Prodct.
Cost-Effective Patent Prosecution and Portfolio Management
Whether a result of financial performance, a cyclical market downturn or a global crisis such as the COVID-19 pandemic, at some point, every IP decision maker will have to plan for cost reductions.
Cost-Effective Patent Prosecution & Portfolio Management
Our go-to resource for general counsel or in-house teams hiring outside IP counsel, with valuable strategies to ‘do more with less.’
Developing an In-House Patent Portfolio Program
A resourceful guide for in-house teams to decide what to patent and when, with a proven systematic approach to portfolio planning.
Synvivia
Cognition IP drafted Synvivia’s initial biotech patent application within weeks and conducted a patentability search on new technologies to direct the company’s IP portfolio development.
Rejuvenation Technologies
Rejuvenation Technologies needed several patent applications to be filed with limited resources before a crucial fundraising round. Cognition IP delivered within a matter of weeks before the fundraising milestone. The company has since engaged for freedom-to-operate searches and ongoing portfolio development.
Tradewind BioScience
Tradewind BioScience needed to understand the IP landscape before deciding if time and resources should be dedicated to a new target. Cognition IP prepared a freedom-to-operate opinion which allowed the company to make a more compelling pitch to investors during a critical fundraising round.
